Cargando…

Predictive Value of Liver Enzymes and Inflammatory Biomarkers for the Severity of Liver Fibrosis Stage in HIV/HCV Co-Infected Patients

OBJECTIVE: The aim of our study was to assess a possible association between plasma inflammatory biomarkers (CRP, IL-6, soluble CD14) and the extent of fibrosis or cirrhosis using a FibroScan® in HIV/HCV co-infected patients. METHODS: This cross-sectional study assessed 60 HIV/HCV co-infected patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Charpentier, Charlotte, Champenois, Karen, Gervais, Anne, Landman, Roland, Joly, Véronique, Le Gac, Sylvie, Larrouy, Lucile, Damond, Florence, Brun-Vézinet, Françoise, Descamps, Diane, Yazdanpanah, Yazdan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602202/ https://www.ncbi.nlm.nih.gov/pubmed/23527135 http://dx.doi.org/10.1371/journal.pone.0059205

Ejemplares similares

Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up
por: Charpentier, Charlotte, et al.
Publicado: (2015)

Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates
por: Visseaux, Benoit, et al.
Publicado: (2015)

First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2)
por: Matheron, Sophie, et al.
Publicado: (2018)

Role of Baseline HIV-1 DNA Level in Highly-Experienced Patients Receiving Raltegravir, Etravirine and Darunavir/Ritonavir Regimen (ANRS139 TRIO Trial)
por: Charpentier, Charlotte, et al.
Publicado: (2013)

SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital
por: Isernia, Valentina, et al.
Publicado: (2020)

Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Langohr, Klaus, et al.
Publicado: (2008)

Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)
por: Charpentier, Charlotte, et al.
Publicado: (2020)

Hepatitis C virus (HCV) incidence among men who have sex with men (MSM) living with HIV: results from the French Hospital Database on HIV (ANRS CO4-FHDH) cohort study, 2014 to 2017
por: Castry, Mathieu, et al.
Publicado: (2021)

Alpha (B.1.1.7) and Delta (B.1.617.2 – AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage
por: Lebourgeois, Samuel, et al.
Publicado: (2022)

Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance
por: Charpentier, Charlotte, et al.
Publicado: (2023)

Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants
por: Lebourgeois, Samuel, et al.
Publicado: (2021)

Influence de la pandémie de la COVID-19 sur le dépistage de l’infection par le VIH
por: Da Conceicao, O., et al.
Publicado: (2021)

Incidence of and risk factors for medical care interruption in people living with HIV in recent years
por: Fournier, Anna Lucie, et al.
Publicado: (2019)

Assessing complex interventions: a systematic review of outcomes used in randomised controlled trials on STI partner notification in high-income countries
por: Sawras, Victoire, et al.
Publicado: (2023)

Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1
por: Bachelard, Antoine, et al.
Publicado: (2022)

HIV-2 Primary Infection in a French 69-Year-Old Bisexual Man
por: Cazals, Nicolas, et al.
Publicado: (2018)

G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to Raltegravir whereas Y143C does not
por: Ni, Xiao-Ju, et al.
Publicado: (2011)

Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

Corrigendum to ‘detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives’
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

Description of the L76V Resistance Protease Mutation in HIV-1 B and “Non-B” Subtypes
por: Charpentier, Charlotte, et al.
Publicado: (2013)

Timing of Intermittent Seminal HIV-1 RNA Shedding in Patients with Undetectable Plasma Viral Load under Combination Antiretroviral Therapy
por: Ferraretto, Xavier, et al.
Publicado: (2014)

Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements
por: Visseaux, Benoit, et al.
Publicado: (2021)

HIV-2 diversity displays two clades within group A with distinct geographical distribution and evolution
por: Visseaux, Benoit, et al.
Publicado: (2021)

Impact of Herpes simplex virus load and red blood cells in cerebrospinal fluid upon herpes simplex meningo-encephalitis outcome
por: Poissy, Julien, et al.
Publicado: (2012)

Réactivation de tuberculose après traitement immunomodulateur pour une infection sévère à SARS-CoV-2
por: Garé, Mathilde, et al.
Publicado: (2023)

Cost‐effectiveness of hepatitis C virus test‐and‐treat and risk reduction strategies among men who have sex with men living with HIV in France
por: Castry, Mathieu, et al.
Publicado: (2022)

HCV and Oxidative Stress in the Liver
por: Ivanov, Alexander V., et al.
Publicado: (2013)

LncRNAs in HCV Infection and HCV-Related Liver Disease
por: Unfried, Juan P., et al.
Publicado: (2020)

Incidence and risk factors for medical care interruption in people living with HIV in a French provincial city
por: Fournier, Anna Lucie, et al.
Publicado: (2020)

β-defensin 1 expression in HCV infected liver/liver cancer: an important role in protecting HCV progression and liver cancer development
por: Ling, Yue-Ming, et al.
Publicado: (2017)

Management of HCV Infection and Liver Transplantation
por: Schiano, Thomas D., et al.
Publicado: (2006)

Illicit massive silicone injections always induce chronic and definitive silicone blood diffusion with dermatologic complications
por: Bertin, Chloé, et al.
Publicado: (2019)

Is Universal HBV Vaccination of Healthcare Workers a Relevant Strategy in Developing Endemic Countries? The Case of a University Hospital in Niger
por: Pellissier, Gérard, et al.
Publicado: (2012)

Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt
por: Cousien, Anthony, et al.
Publicado: (2014)

Epidemiology and Elimination of HCV-Related Liver Disease
por: Pradat, Pierre, et al.
Publicado: (2018)

miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation
por: Bulfoni, Michela, et al.
Publicado: (2021)

Molecular confirmation of HIV-1 and HIV-2 coinfections among initially serologically dually-reactive samples from patients living in West Africa
por: Tchounga, Boris K., et al.
Publicado: (2023)

Detection of Pandemic (H1N1) 2009 Virus in Patients Treated with Oseltamivir
por: Boutolleau, David, et al.
Publicado: (2010)

The use of HCV positive donors among non-HCV infected liver transplant recipients
por: Zaffar, Duha, et al.
Publicado: (2022)

HIV-1 Tropism and Liver Fibrosis in HIV–HCV Co-Infected Patients
por: Abravanel, Florence, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7uustf013ufptoq0v3fssjq8e1